Renaissance Technologies
ELOX

Renaissance Technologies’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Renaissance Technologies’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,338
Closed -$23K – 4554
2022
Q3 		$23K Sell
3,338
-1,147
-26% -$13.8K ﹤0.01% 3883
2022
Q2 		$48K Buy
+4,485
New +$61.9K ﹤0.01% 4002
2021
Q3 		– Sell
-4,098
Closed -$326K – 3983
2021
Q2 		$326K Buy
+4,098
New +$342K ﹤0.01% 3119
2021
Q1 		– Sell
-993
Closed -$158K – 3846
2020
Q4 		$158K Sell
993
-495
-33% -$60.5K ﹤0.01% 3192
2020
Q3 		$157K Sell
1,488
-770
-34% -$92.2K ﹤0.01% 3152
2020
Q2 		$274K Sell
2,258
-1,012
-31% -$115K ﹤0.01% 3072
2020
Q1 		$256K Sell
3,270
-143
-4% -$23.3K ﹤0.01% 3029
2019
Q4 		$1M Buy
3,413
+2,905
+572% +$585K ﹤0.01% 2627
2019
Q3 		$92K Buy
+508
New +$145K ﹤0.01% 3268
2018
Q3 		– Sell
-250
Closed -$171K – 3635
2018
Q2 		$171K Buy
+250
New +$162K ﹤0.01% 3097

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Renaissance Technologies's ELOX Position: Q4 2022 in Review

Renaissance Technologies sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 3,338 shares — an estimated $23K sold.

Renaissance Technologies first reported a position in ELOX in Q2 2018 and held it in 10 quarters. The position peaked at $1M in Q4 2019. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Renaissance Technologies reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Renaissance Technologies sold 3,338 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $23K.
  • Renaissance Technologies first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
  • Renaissance Technologies's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $1M in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.